Page 21 - Read Online

Miura et al. Vessel Plus 2019;3:1 I http://dx.doi.org/10.20517/2574-1209.2018.69 Page 13 of 15

Soc Trans 2007;35:454-8.
40. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, et al. Triglyceride-rich lipoproteins and high-density lipoprotein
cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011;32:1345-61.
41. Harangi M, Szentpéteri A, Nádró B, Lőrincz H, Seres I, et al. HDL subfraction distribution and HDL function in untreated dyslipidemic
patients. Vessel Plus 2017;1:166-73.
42. Assmann G, Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation 2004;109:III8-14.
43. Peshavariya H, Dusting GJ, Di Bartolo B, Rye KA, Barter PJ, et al. Reconstituted high-density lipoprotein suppresses leukocyte
NADPH oxidase activation by disrupting lipid rafts. Free Radic Res 2009;43:772-82.
44. Calabresi L, Franceschini G, Sirtori CR, De Palma A, Saresella M, et al. Inhibition of VCAM-1 expression in endothelial cells by
reconstituted high density lipoproteins. Biochem Biophys Res Commun 1997;238:61-5.
45. Mackness B, Hine D, Liu Y, Mastorikou M, Mackness M. Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by
endothelial cells. Biochem Biophys Res Commun 2004;318:680-3.
46. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, et al. Monocyte transmigration induced by modification of low density lipoprotein
in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density
lipoprotein. J Clin Invest 1991;88:2039-46.
47. Epand RM, Stafford A, Leon B, Lock PE, Tytler EM, et al. HDL and apolipoprotein A-I protect erythrocytes against the generation of
procoagulant activity. Arterioscler Thromb 1994;14:1775-83.
48. Nofer JR, Walter M, Kehrel B, Wierwille S, Tepel M, et al. HDL3-mediated inhibition of thrombin-induced platelet aggregation and
fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol
1,4,5-tris-phosphate. Arterioscler Thromb Vasc Biol 1998;18:861-9.
49. Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, et al. LDL cholesterol and the development of stroke subtypes and coronary heart
disease in a general Japanese population: the Hisayama study. Stroke 2009;40:382-8.
50. Kim YS, Sung HJ, Son SJ, Lim J, Kang YW, et al. Triglyceride (TG) down-regulates expression of MCP-1 and CCR2 in PMA-derived
THP-1 macrophages. Genes Genomics 2013;35:125-30.
51. Labreuche J, Deplanque D, Touboul PJ, Bruckert E, Amarenco P. Association between change in plasma triglyceride levels and risk of
stroke and carotid atherosclerosis: systematic review and meta-regression analysis. Atherosclerosis 2010;212:9-15.
52. Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic
review. Atherosclerosis 2008;196:489-96.
53. Kontush A, Chapman MJ. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol
2010;21:312-8.
54. Tiozzo E, Gardener H, Hudson BI, Dong C, Della-Morte D, et al. High-density lipoprotein subfractions and carotid plaque: the Northern
Manhattan study. Atherosclerosis 2014;237:163-8.
55. Chei CL, Yamagishi K, Kitamura A, Kiyama M, Imano H, et al. High-density lipoprotein subclasses and risk of stroke and its subtypes
in Japanese population: the circulatory risk in communities study. Stroke 2013;44:327-33.
56. Wang X, Dong Y, Qi X, Huang C, Hou L. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis.
Stroke 2013;44:1833-9.
57. Xie L, Wu W, Chen J, Tu J, Zhou J, et al. Cholesterol levels and hemorrhagic stroke risk in East Asian versus Non-East Asian
populations: a systematic review and meta-analysis. Neurologist 2017;22:107-15.
58. Mathiesen EB, Joakimsen O, Bønaa KH. Prevalence of and risk factors associated with carotid artery stenosis: the Tromsø study.
Cerebrovasc Dis 2001;12:44-51.
59. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, et al. Cardiovascular risk factors in childhood and carotid artery intima-
media thickness in adulthood: the cardiovascular risk in young Finns study. JAMA 2003;290:2277-83.
60. Vouillarmet J, Helfre M, Maucort-Boulch D, Riche B, Thivolet C, et al. Carotid atherosclerosis progression and cerebrovascular events
in patients with diabetes. J Diabetes Complications 2016;30:638-43.
61. Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, et al. Effect of lower targets for blood pressure and LDL cholesterol on
atherosclerosis in diabetes: the SANDS randomized trial. JAMA 2008;299:1678-89.
62. Kitagami M, Yasuda R, Toma N, Shiba M, Nampei M, et al. Impact of hypertriglyceridemia on carotid stenosis progression under
normal low-density lipoprotein cholesterol levels. J Stroke Cerebrovasc Dis 2017;26:1793-800.
63. Laufs U, Gertz K, Dirnagl U, Böhm M, Nickenig G, et al. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial
nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 2002;942:23-30.
64. Cheng ZJ, Dai TM, Shen YY, He JL, Li J, et al. Atorvastatin pretreatment attenuates ischemic brain edema by suppressing aquaporin 4.
J Stroke Cerebrovasc Dis 2018;27:3247-55.
65. Zhu MX, Lu C, Xia CM, Qiao ZW, Zhu DN. Simvastatin pretreatment protects cerebrum from neuronal injury by decreasing the
expressions of phosphor-CaMK II and AQP4 in ischemic stroke rats. J Mol Neurosci 2014;54:591-601.
66. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/
SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A
report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the
American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons,
American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis